Willingham Emily, Agras Koray, de Souza Antonio E P, Konijeti Ramdev, Yucel Selcuk, Rickie William, Cunha Gerald R, Baskin Laurence S
Institute for the Study and Treatment of Hypospadias, Department of Urology, School of Medicine, University of California, San Francisco, 94143, USA.
J Urol. 2006 Aug;176(2):728-33. doi: 10.1016/j.juro.2006.03.078.
We investigated the role of steroid receptors in normal and abnormal genital tubercle development in males and females. We hypothesized that progesterone receptor expression might be involved in abnormal development in both sexes.
We examined the effects of medroxyprogesterone acetate on steroid receptor mRNA expression and assessed the involvement of androgen receptor in the action of medroxyprogesterone acetate on genital tubercle development using androgen receptor deficient (Tfm) mice.
Quantitative reverse transcriptase polymerase chain reaction and morphological results demonstrated a pattern of virilized females and feminized males in medroxyprogesterone acetate exposed embryos. Progesterone receptor was the only steroid receptor examined that did not differ between medroxyprogesterone acetate treated males and vehicle treated females. At the morphological level in utero exposure to medroxyprogesterone acetate from gestational days 12 to 17 feminized male genital tubercles, producing a more proximal urethral opening. Female fetuses exposed for the same period exhibited virilized genitalia, with a more distal urethral opening. We also exposed Tfm mice to medroxyprogesterone acetate to assess the role of androgen receptor in the activity of medroxyprogesterone acetate. These medroxyprogesterone acetate exposed mice did not differ morphologically from vehicle treated Tfm mice, indicating that medroxyprogesterone acetate requires androgen receptor to elicit genital tubercle abnormalities.
The increase of progesterone receptor mRNA expression in males and the decrease in females as a result of exposure to medroxyprogesterone acetate, which also causes urethral abnormalities in both sexes, suggests a previously unidentified role for progesterone receptor, possibly interacting with androgen receptor, in anomalous genital tubercle development.
我们研究了类固醇受体在男性和女性正常及异常生殖结节发育中的作用。我们假设孕酮受体表达可能参与了两性的异常发育。
我们检测了醋酸甲羟孕酮对类固醇受体mRNA表达的影响,并使用雄激素受体缺陷(Tfm)小鼠评估了雄激素受体在醋酸甲羟孕酮对生殖结节发育作用中的参与情况。
定量逆转录聚合酶链反应和形态学结果显示,在暴露于醋酸甲羟孕酮的胚胎中出现了雌性雄性化和雄性雌性化的模式。孕酮受体是所检测的唯一一种在醋酸甲羟孕酮处理的雄性和溶剂处理的雌性之间没有差异的类固醇受体。在形态学水平上,从妊娠第12天到17天子宫内暴露于醋酸甲羟孕酮会使雄性生殖结节雌性化,产生更近端的尿道口。同期暴露的雌性胎儿表现出雄性化的生殖器,尿道口更靠远端。我们还将Tfm小鼠暴露于醋酸甲羟孕酮以评估雄激素受体在醋酸甲羟孕酮活性中的作用。这些暴露于醋酸甲羟孕酮的小鼠在形态上与溶剂处理的Tfm小鼠没有差异,表明醋酸甲羟孕酮需要雄激素受体来引发生殖结节异常。
暴露于醋酸甲羟孕酮导致雄性孕酮受体mRNA表达增加而雌性减少,这也导致了两性的尿道异常,提示孕酮受体在异常生殖结节发育中可能具有先前未被认识的作用,可能与雄激素受体相互作用。